| 标题 |
 A Phase II Study of Single Agent Aspacytarabine (BST-236) in Adults Unfit for Intensive Chemotherapy with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) or Higher Risk Myelodysplastic Syndromes (R/R HR MDS) |
| 网址 | |
| DOI |
10.1182/blood-2023-185609
doi
|
| 其它 |
期刊：Blood 作者：Marie Anne Hospital; Thomas Cluzeau; Alice Garnier; Giovanni Marconi; Emmanuelle Tavernier; et al 出版日期：2023-11-02 |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)
DW
老的火龙果
无极微光
秋风
OK
xing_xing
Nole
aaaa
cdercder
贪玩的秋柔
coolru
DOC_XIONG
Enigma_GEB
aajhajkahna
Ali
Kao
七听
李杰杰
科研狗
Criminology34
皖公网安备34019202002308
